Treatment of Fifth Metatarsal Zone 3 Fractures

Launched by OSTFOLD HOSPITAL TRUST · Apr 14, 2021

Keywords

ClinConnect Summary

This clinical trial is studying how to treat a specific type of foot fracture called a Zone 3 fracture of the fifth metatarsal, which is a bone in the foot that can suffer from stress fractures. The researchers want to find out if using a surgical method called osteosynthesis with an intramedullary screw (a type of internal fixation) helps patients recover faster and experience less pain when they start walking again compared to using a non-surgical method, such as wearing a walking boot.

To participate in the trial, potential volunteers should be between the ages of 65-74 or 23-740 years old and must have a confirmed Zone 3 fracture. However, individuals with certain conditions, like open fractures, severe nerve damage, or other injuries that could complicate treatment, will not be eligible. Participants can expect to receive care and follow-up at one of the study centers and will be part of an important effort to improve the understanding of the best treatment options for this type of fracture.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Zone 3 fracture
• Exclusion Criteria:
• • Neuropathy
• • Open fractures
• • High energy injuries
• • Associated injury in the same or opposite extremity that may affect treatment or rehabilitation
• • Pressure ulcer(s)
• • Lack of consent competence
• • Fracture radiologically confirmed more than six months ago
• • No possibility of follow-up at one of the study centers
• • Established pseudarthrosis
• • Medical condition that contraindicates surgery
• • Non-compliance